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Introduction
Parkinson’s disease is the most common neuro-
degenerative movement disorder with a prevalence of about 
2% in the population over the age of 65 years [1].
PD has no known cause. The exposure of the human 
population to environmental contaminants is recognized 
as a significant contributing factor for the development 
of Parkinson’s disease and other forms of parkinsonism. 
Evidence exists to suggest that age and gender and some 
environmental factors (pesticide exposure, occupation) are 
associated with the development of PD. Instead, tobacco 
use, and caffeine consumption are believed to be inversely 
associated to the development of PD, tobacco and black tea 
having a protective effect on age at onset in genetic PD – 
LRRK2 [2, 3].
PD varies in age of symptom onset, rate of progression, 
severity of motor and non- motor symptoms, extent of 
central and peripheral inflammation, maybe, because 
genetic and environmental factors act synergistically in PD 
pathogenesis. 
A lot of recent research has focused particularly on 
genetic causes of PD. Although several genes have been 
implicated as monogenic causes of the disease, these genetic 
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Abstract
Background: Parkinson’s disease (PD) – the most common neuro-degenerative movement disorder – is considered a result of a multifactorial pathogenic 
process modulated by cumulative and interactive effects of genes and exposures. An environmental exposure could enhance or create dopaminergic 
neurons vulnerability and increase PD risk. The purpose of the study was to find if excessive exposure to toxic environmental factors may influence 
clinical pattern of PD.
Material and methods: The study was conducted on 111 patients diagnosed with PD, study group being defined as PD exposed to toxins (33 patients), 
control group including PD patients without toxin exposure (78 patients). General epidemiological data and clinical data were recorded.
Results: Toxin exposure was found in 33 patients (29.73%), more of them – men and rural residents. Toxin exposed PD patients had an insignificantly 
younger age. The most common disease phenotype in the study group was the akinetic-rigid phenotype (64.7%, p = 0.040), bradykinesia being the most 
common sign at the disease onset (57.6%, p = 0.008). Levodopa equivalent daily dose also was higher in the study group (659.02 ± 232.46, p = 0.042).
Conclusions: Excessive exposure to toxic environmental factors may influence the clinical pattern of PD. In this study the akinetic-rigid type was the 
predominant disease phenotype associated with toxin exposure. Doses needed for treatment were higher in PD patients exposed to toxins, as an indicator 
of a more severe motor impairment in this group.
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mutations are only responsible for approximately 10% of 
cases, indicating that the majority of PD is the result of a 
multifactorial pathogenic process [4] and environmental 
causes also may play a role in developing the disease. Rare 
(causative) and common (risk) variants associated with PD 
have been identified, including SNCA and LRRK2. 
Some authors propose that environmental factors 
(pesticides and infections) increase the risk for PD via the 
immune system [5], because several of the genes associated 
with PD risk, function in the immune system. Peripheral 
immune activation and neuroinflammation in the brain 
contribute to neuropathology and neurodegeneration [6]. 
An environmental exposure that increases α-synuclein 
expression and/or inflammatory cytokine secretion could 
create a state in which dopaminergic neurons are vulnerable 
to immune-driven stress [5]. Increased kinase activity 
associated with the G2019S LRRK2 mutation may contribute 
to shifts in immune cell population frequencies and function 
[7]. In response to an exposure or experience, physiological 
and epigenetic regulation can occur, and the resulting cell-
signaling cascades could influence disease pathogenesis [8]. 
The immune system’s response to exposure may depend 
on the genetic variations or mutations of SNCA, LRRK2, 
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PINK1, and MHCII. There is a gene-by-environment-by-
immune- system triangle in PD pathogenesis [5].
So, PD risk can be modulated by cumulative and 
interactive effects of genes and exposures [4]. One study 
showed that gene-environmental interactions increased the 
OR for PD from about 1.6 at the individual level up to OR 
12.6 for some combinations [4].
Environmental factors such as drinking well water, rural 
living, farming, exposure to agricultural chemicals, farm 
and industrial compounds, exposure to different metals and 
industrial compounds as manganese, lead, copper, iron, zinc, 
aluminium or amalgam have been reported to be associated 
with the risk of developing PD [9-11].
So far, is known that toxin exposure can promote PD by 
several mechanisms: oxidative stress, dopamine homeosta-
sis, calcium homeostasis, alpha-synuclein fibrillization, mi-
tochondrial dysfunction neuroinflammation [12].
As toxic exposures to these compounds can result in 
a spectrum of PD and related disorders, it is imperative 
to identify, not only their mechanisms of action, but also 
shared clinical patterns to further delineate the resultant 
disorders for improving diagnosis, preventive strategies and 
therapeutic interventions [12].
Material and methods
These are preliminary data of a cohort study of Moldovan 
patients with incident of Parkinson’s disease. Diagnosis 
of PD was based on widely acknowledged criteria [13]. 
Structured interview on medical and drug history, family 
history of neurological and psychiatric diseases, years of 
education, all previous and current occupations, previous 
and current lifestyle habits, details regarding exposure to 
pesticides, and other toxins were recorded and a general 
neurological and medical examination conducted. Severity 
of parkinsonism and disability were assessed by the Modified 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) 
[14]. Patients were subclassified at baseline into three groups 
according to Jankovic method: tremor dominant (TD), 
akinetic-rigid (AR) or intermediate (IND) [15]. The groups 
were defined as: (1) Toxic substances contact present (ToxSC +) 
– study group; and (2) absent (ToxSC-) – control group. 
The data analysis was performed via statistical program 
StatDirect, using descriptive, variation, and correlational 
analysis. Student’s t tests or Mann-Whitney tests were used 
as appropriate. P values less than 0.05 were considered 
statistically significant. 
Results and discussion
These are preliminary data of a cohort study of Moldovan 
patients with incident Parkinson’s Disease (PD). The study 
group consisted of 111 consecutive PD patients. The mean 
age in the cohort was 64.87 ± 7.69 years. By sexes, PD patients, 
were distributed as follows:  48 were women (43.2%) and 63 
were men (56.8%)). 
Contact with toxic substances (ToxSC), was recorded 
by history taking about previous and current occupations, 
previous and current lifestyle habits, exposure to pesticides, 
and other toxins; and was found in 33 patients (29.73%). In 
this study, excessive exposure to toxic environmental factors 
was more common in men and rural residents. Among 
ToxSC+ patients, 30 patients (90.9%) were men and 3 (9.1%) 
patients were women (p=0.000). Nineteen of the toxin 
exposed patients (57.6%, p=0.000) were rural residents. 
Similarly, in a meta-analysis of PD risk, RR was statistically 
significant for: rural living (RR = 1.43; 95% CI = 1.22–
1.69), farming (RR = 1.24; 95% CI = 1.12–1.37) and well-
water consumption (RR = 1.30; 95% CI = 1.12–1.51); the 
association between pesticide use and PD was statistically 
significant for all studies combined (RR = 1.22; 95% Cl = 
1.18–1.27); and use of herbicides (RR = 1.20; 95% CI = 1.06–
1.36) or insecticides (RR = 1.32; 95% CI = 1.14–1.52) was 
associated with statistically significantly increased PD risk 
[8]. Also, in Norwegian ParkWest study, agricultural work 
was associated with a higher risk of PD (OR 1.75 (1.03–3.0) 
P 5 0.009): PD patients were more often agricultural workers 
than controls (23% PD vs 14.4% of controls, P 5 0.026 [χ2 
test], odds ratio [OR] 1.75 [1.03–3.0]); whether patients or 
controls were born and raised on a farm did not affect the 
risk of PD [9].
Different toxic exposure was found in the study group: 
petrol intake (10 patients (9%)), diesel intake (4 patients 
(3.6%)), petrol + diesel intake (6 patients (5.4%)), exposure 
to pesticides (7 patients (6.3%)), to solvents – 3 patients 
(2.7%), to reinforced concrete (polystyrene) – 1 patient 
(0.9%), to welding gas – 1 patient (0.9%), to freon – 1 patient 
(0.9%). 
In a study, prevalence of parkinsonism among active 
male welders age 40 to 69 statewide was 977 to 1336 cas-
es/100000 population. The prevalence of Parkinsonism was 
higher among welders vs age-standardized data for the gen-
eral population (prevalence ratio – 10.19, 95% CI 4.43 to 
23.43). The authors concluded that the estimated prevalence 
of parkinsonism was higher within a sample of male weld-
ers vs the general population of males [16]. By contrast, the 
results of Danish Cohort Study (5867 Danish welders and 
1735 non- welding metal workers exposed to welding fume 
from general Danish population in 1987–2008) do not sup-
port the hypothesis that welders are at increased risk for 
Parkinson’s disease [17]. It was established that parkinson-
ism can occur after chronic exposure to high levels of man-
ganese, usually above the permissible exposure limit ceiling 
at 5 mg/m3 total dust set by the Occupational Safety and 
Health Administration [18].
In the present study was found that in ToxSC+ patients, 
the disease began at an insignificantly younger age than in 
ToxSC- patients (59.24 ± 6.93 vs 60.95 ± 8.86 years, p <0.005). 
By history taking, was established, that bradykinesia was the 
most often PD onset symptom in ToxSC+ patients (57.6%, p 
= 0.008). Applying the Jankovic method of defining PD mo-
tor phenotype, the more frequent PD phenotype in ToxSC+ 
patients was the akinetic-rigid one (64.7%, p = 0.040). 
There are interesting clinical differences between 
subgroups of PD patients (tremor dominant (TD) vs postural 
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instability gait difficulties PIGD), provided by literature.  In 
a study, a protective association of alcohol and smoking was 
only seen in postural instability gait difficulties (PIGD) – 
akinetic-rigid PD and not in tremor dominant (TD) PD [9], 
may be because the underlying pathogenic mechanisms are 
heterogeneous, including environmental exposure.
Levodopa equivalent daily dose needed to compensate 
motor impairment in ToxSC+ patients was significantly 
higher than in the control group (659.02 ± 232.46 vs 483.77 
± 355.41, p = 0.042), as an indicator of a more severe motor 
disability in PD patients exposed to environmental toxic 
factors.
Overall, studies suggest that environmental insults may 
play an important role in the appearance and progression of 
PD pathology [19],  PD onset and its clinical presentation 
may be due to a combination of external aggressors and 
individual genetic susceptibility to this aggression; and 
low incidence of PD suggests that gene-environment 
interactions play an important role in the process. According 
to our results excessive exposure to toxic environmental 
factors was more common associated with the akinetic-rigid 
type of Parkinson’s disease – a phenotype with more severe 
motor impairment. And ToxSC+ patients needed higher 
doses of dopaminergic drugs – an indicator of a more motor 
impairment in this category.
Conclusions
Environmental factors may play an important role in 
the appearance, progression and clinical presentation of 
Parkinson’s disease. This study, replicated that excessive 
exposure to toxic environmental factors is more commonly 
found in men and rural residents. According to the received 
results, toxin exposure was more frequently associated with 
the akinetic-rigid type of Parkinson’s disease and with higher 
doses of dopaminergic drugs needed for motor symptoms 
control, indicating a higher severity of motor impairment in 
toxin exposed PD patients.
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